医療用エラストマーの世界市場予測（2022年～2027年）

世界の医療用エラストマーの市場規模は、2020年に65億9,600万米ドルとなり、予測期間中に9.01％のCAGRで成長し、2027年に120億6,600万米ドルになると予測されています。市場を牽引する要因には、医療用製品の製造に使用される安全でハロゲンフリーのポリマーの需要が急増していることや、医療用エラストマーに対する意識の高まり、高品質なヘルスケア製品の採用などが挙げられます。しかし、一部のエラストマーには生体適合性の問題があり、また世界的に厳しい規制要件があるため、市場成長を阻害する可能性があります。

当レポートでは、世界の医療用エラストマー市場について調査し、市場規模や予測、COVID-19の影響、市場の促進要因および課題、市場動向、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19の影響
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• 業界のバリューチェーン分析

第5章 世界の医療用エラストマー市場分析：タイプ別

• イントロダクション
• 熱硬化性エラストマー
  • シリコーン
  • その他
• 熱可塑性エラストマー

第6章 世界の医療用エラストマー市場分析：用途別

• イントロダクション
• インプラント
• シリンジ
• 医療用バッグ
• 手袋
• 医療用チューブ
• その他

第7章 世界の医療用エラストマー市場分析：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • ドイツ
  • スペイン
  • 英国
  • イタリア
  • フランス
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • タイ
  • 台湾
  • インドネシア
  • その他

第8章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の有利性
• 合併、買収、契約、コラボレーション
• ベンダーの競合マトリックス

第9章 企業プロファイル

• Anchor Drilling
• Arkema Group
• BASF
• The Dow Chemical Company
• Biomerics
• Solvay
• Celanese Corporation
• Teknor Apex
• Tekni-Plex
• Trelleborg Sealing Solutions.
• Kuraray

The global medical elastomers market is expected to grow at a CAGR of 9.01% over the forecast period to reach a market size of US$12.066 billion by 2027, increasing from US$6.596 billion in 2020. Medical elastomer refers to a natural or synthetic polymer having elastic properties that are used for manufacturing medical products.

They are extensively used in the manufacturing of cardiovascular devices, prosthetic devices, general medical care products, transdermal therapeutic systems, orthodontics, etc. The extensive use of elastomers is due to their biocompatibility, durability, design flexibility, and favourable performance/cost ratios. The growth may be attributed to the surge in demand for safe and halogen-free polymers used in manufacturing medical products. Growing awareness and the adoption of high-quality healthcare products will also drive the demand for medical elastomers during the given forecast period. The biocompatibility concerns of some elastomers coupled with the stringent regulatory requirements across the globe might hamper the growth of the medical elastomer market during the given time frame.

In addition, healthcare facilities use a huge variety of elastomers at every level of operations, ranging from biocompatibility, sterility, and low leaching levels. Natural Rubber Latex (NRL) surgical gloves are disposable gloves made of natural rubber latex that is used in surgeries to protect both the patient and the surgeon from contamination. These types of gloves hold a prominent share in the surgical glove market as they are commonly used by surgeons across the globe due to the low cost associated with them. However, growing allergies due to latex among surgeons along with the ban on powdered latex surgical gloves can restrain the market growth during the forecast period. Also, today's implants and prosthetics are also made of medical-grade elastomers, making use of the material's flexibility to achieve specific results. Dental implants and prosthetics are mostly used to fill cavities in the mouth or to replace them with a concrete solution. According to the World Health Organization, nearly 3 billion people across the world are currently affected by oral health problems. A dental implant is a type of oral prosthetic in which the gum is opened and a prosthetic crown is placed in the cavity.

Additionally, the outbreaks of COVID-19 have led to a meteoric rise in the demand for medical products, which is critically important to reducing the impact of the pandemic. Besides, the rising cases of the corona have made it the governments of all countries' top priority to increase their medical equipment capabilities. Furthermore, the public health system is contributing to the flow of funds toward improving hospital infrastructure to address pandemic challenges, propelling the market growth during the forecast period.

The market is expanding due to the growing geriatric population.

The global population is ageing, and the proportion of elderly people in the total population is increasing in every country. There is no doubt about the global prevalence of chronic diseases among the elderly. According to the United Nations' recent World Population Prospects report, by 2050, one in every six people in the world will be over the age of 65 (16%), from one in every eleven in 2019 (9%), and the number of people aged 80 or older is expected to triple, from 143 million in 2019 to 426 million in 2050.

The rising number of surgical procedures globally is projected to fuel the market's growth in the forecast period.

The increasing number of surgeries in the world is propelling market growth opportunities for manufacturers and vendors during the forecast period. For example, in the United Kingdom, the market is poised to grow in the coming years as surgeries are the most important treatment offered by the National Health Service in secondary care within the country. This is further supported by the growing number of surgeons, especially with the rise of several female surgeons contributing to a surge in market growth in the forecast period.

North America is holding a significant share of the market

The North American region is expected to hold a significant share during the forecast period owing to the fact that there are an increasing number of players involved in the provision of advanced and enhanced varieties of elastomers. In addition, increasing investments in the R&D of better medical equipment will contribute to the development of the well-established healthcare and medical equipment sector. In addition, the Asia-Pacific region is expected to witness a significant increase in its market share over the forecast period, which is attributable to the fact that there are initiatives being taken by the government in order to boost the healthcare sector. In addition, there is an increasing number of individuals, such as children and the geriatric population, that are diagnosed with chronic problems that require diagnosis and treatment.

Recent Developments

• United Soft Plastics developed a custom extruded thermoplastic elastomer film in October 2021 that provides a high level of patient support and treatment-friendly wound healing. The developmental grade contributes significantly to increased protection for patients and medical nursing staff.
• DuPont launched new medical elastomer mixers in September 2021, in response to increased supply needs from DuPontTM LiveoTM Healthcare Solutions customers.
• Drake Medical Plastics Ltd and Foster Corporation announced a global sales collaboration in May 2021 to provide customers with machinable shapes from Foster's full range of polymer compounds. This agreement makes it easier for customers to obtain the medical polymer shapes they require.
• Alsiano and their partner, Actega, launched a wide range of premium thermoplastic elastomers (TPEs) for medical applications such as breathing masks, ventilation tubes, and IV sets in September 2020. Biocompatible ProvaMed® TPE compounds strive to meet the highest purity, cleanliness, and hygiene standards.

COVID-19 impact on Medical Elastomers Market

Coronavirus had a significant and positive impact on the development of medical elastomers, particularly those used in syringes and vial stoppers. Furthermore, rising demand for speciality elastomers is expected for PPE equipment manufacturing, medical devices, and other equipment as a result of significant investments in the healthcare sector to adapt to the unprecedented global pandemic challenge.

Market Segmentation:

• By Type

Thermoset Elastomer

Silicone

Others

Thermoplastic Elastomer

• By Application

Implants

Syringes

Medical Bags

Gloves

Medical Tubes

Others

• By Geography

North America

• United States
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• Germany
• Spain
• United Kingdom
• Italy
• France
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Others

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Taiwan
• Indonesia
• Others

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Overview
• 1.2. Covid 19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. Research Methodology

• 2.1. Research Data
• 2.2. Assumptions

3. Executive Summary

• 3.1. Research Highlights

4. Market Dynamics

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. Global Medical Elastomers Market Analysis, By Type (Value In US$ Million)

• 5.1. Introduction
• 5.2. Thermoset Elastomer
  • 5.2.1. Silicone
  • 5.2.2. Others
• 5.3. Thermoplastic Elastomer

6. Global Medical Elastomers Market Analysis, By Application (Value In US$ Million)

• 6.1. Introduction
• 6.2. Implants
• 6.3. Syringes
• 6.4. Medical Bags
• 6.5. Gloves
• 6.6. Medical Tubes
• 6.7. Others

7. Global Medical Elastomers Analysis, By Geography (Value In US$ Million)

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. United States
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. Spain
  • 7.4.3. United Kingdom
  • 7.4.4. Italy
  • 7.4.5. France
  • 7.4.6. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. Japan
  • 7.6.3. India
  • 7.6.4. South Korea
  • 7.6.5. Thailand
  • 7.6.6. Taiwan
  • 7.6.7. Indonesia
  • 7.6.8. Others

8. Competitive Environment and Analysis

• 8.1. Major Players and Strategy Analysis
• 8.2. Emerging Players and Market Lucrativeness
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Vendor Competitiveness Matrix

9. Company Profiles

• 9.1. Anchor Drilling
• 9.2. Arkema Group
• 9.3. BASF
• 9.4. The Dow Chemical Company
• 9.5. Biomerics
• 9.6. Solvay
• 9.7. Celanese Corporation
• 9.8. Teknor Apex
• 9.9. Tekni-Plex
• 9.10. Trelleborg Sealing Solutions.
• 9.11. Kuraray